SCHEMBL17308357

SCHEMBL17308357

CCc1nc2c(F)cccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDAH1 O94760 1/20 0.53
GAA P10253 3/20 0.43
MGAM O43451 2/20 0.43
SI P14410 2/20 0.43
MGAM2 Q2M2H8 2/20 0.43
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
CHEK1 O14757 1/20 0.40
EGLN1 Q9GZT9 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.38
POLB P06746 1/20 0.38
SLC40A1 Q9NP59 4/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5744116 0.82 EGLN1 (0.42) GAAMGAMSIMGAM2CHEK1
SCHEMBL4270442 0.82 EGLN1 (0.42) GAAMGAMSIMGAM2CHEK1
SCHEMBL4061481 0.82 MGAM (0.40) GAAMGAMSIMGAM2CHEK1
Hydrochloric Acid SCHEMBL23782097 0.81 EGLN1 (0.41) GAAMGAMSIMGAM2CHEK1
Hydrochloric Acid SCHEMBL23497492 0.81 EGLN1 (0.41) GAAMGAMSIMGAM2CHEK1
SCHEMBL2899660 0.80 DDAH1 (0.55) DDAH1GAAADORA3ADORA2AADORA1
SCHEMBL30518181 0.80 DDAH1 (0.55) DDAH1GAAMGAMSIMGAM2
SCHEMBL4919548 0.80 DDAH1 (0.55) DDAH1GAAMGAMSIMGAM2
Hydrochloric Acid SCHEMBL23497490 0.79 EGLN1 (0.40) GAAMGAMSIMGAM2CHEK1
SCHEMBL22075724 0.79 SLC40A1 (0.40) GAAMGAMSIMGAM2EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150344434-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344434-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT3 DDAH1 589/4885GAA 3431/4885MGAM 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.